Status:
COMPLETED
Oxaliplatin and 5-FU Based Preoperative Chemoradiation
Lead Sponsor:
Oslo University Hospital
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Oxaliplatin and 5FU based preoperative chemoradiation in rectal cancer.
Detailed Description
Effect of treatment, safety profile and quality of life scorings.
Eligibility Criteria
Inclusion
- Rectal cancer
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT00278694
Start Date
September 1 2005
End Date
February 1 2016
Last Update
September 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RRHF
Oslo, Norway, 0027